AU Patent

AU663471B2 — Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Assigned to Merck Sharp and Dohme LLC · Expires 1995-10-12 · 31y expired

What this patent protects

The invention relates to the novel compound mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing said compound.

USPTO Abstract

The invention relates to the novel compound mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing said compound.

Drugs covered by this patent

Patent Metadata

Patent number
AU663471B2
Jurisdiction
AU
Classification
—
Expires
1995-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.